Ticker
ALZCUR
Analysis
Alzecure Pharma Ab investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to ALZCUR.
Alzecure Pharma Ab investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to ALZCUR.
ALZCUR
Stock
$54.1M
Health Technology
Biotechnology
SEK
Alzecure Pharma Ab may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
AlzeCure Pharma Enters Into A Collaboration And Out-Licensing Agreement With Lilly For Alzheimer's
AlzeCure Pharma carries out previously announced rights issue of approximately SEK 30.1 million and publishes information
STOCKHOLM, SE / ACCESS Newswire / May 26, 2026 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - The shareholders of AlzeCure Pharma AB, reg. no. 559094-8302 (the "Company") are hereby ...
AlzeCure Pharma carries out a fully secured rights issue of approximately SEK 30.1
STOCKHOLM, SE / ACCESS Newswire / April 20, 2026 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the ne...
Review valuation context for Alzecure Pharma Ab.
Review future growth context for Alzecure Pharma Ab.
Review past performance context for Alzecure Pharma Ab.
Review financial health context for Alzecure Pharma Ab.
Review dividend context for Alzecure Pharma Ab.
Review management context for Alzecure Pharma Ab.
Review ownership context for Alzecure Pharma Ab.
Review other information context for Alzecure Pharma Ab.
Review community context for Alzecure Pharma Ab.